DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 25 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $357,607 | 0.42% |
| COOPERMAN LEON G | 868,413 | $1,328,672 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 25,110 | $38,418 | 0.02% |
| Legend Financial Advisors, Inc. | 1,000 | $1,530 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $282,851 | 0.00% |
| STATE STREET CORP | 66,629 | $101,942 | 0.00% |
| TORONTO DOMINION BANK | 24 | $0 | 0.00% |
| MORGAN STANLEY | 57,188 | $87,498 | 0.00% |
| BlackRock Inc. | 71,670 | $109,655 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $55,175 | 0.00% |
| Citadel Advisors | 1,100 | $1,683 | 0.00% |
| Citadel Advisors | 100 | $153 | 0.00% |
| Citadel Advisors | 42,234 | $64,618 | 0.00% |
| SIMPLEX TRADING, LLC | 3,526 | $5 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,986 | $9 | 0.00% |
| Renaissance Technologies | 64,508 | $99 | 0.00% |
| TD Waterhouse Canada Inc. | 1,570 | $3,104 | 0.00% |
| ROYAL BANK OF CANADA | 805 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 782,989 | $1,197,973 | 0.00% |
| UBS Group AG | 2,038 | $3,118 | 0.00% |
External links
This page lists DIAMEDICA THERAPEUTICS INC's shareholders in Q1 2023. To view DIAMEDICA THERAPEUTICS INC's shareholder history, click here.